Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 10 2021
Historique:
received: 31 03 2021
accepted: 27 09 2021
entrez: 9 10 2021
pubmed: 10 10 2021
medline: 27 1 2022
Statut: epublish

Résumé

There have been no report of objective clinical characteristics or prognostic factors that predict fatal outcome of acute respiratory distress syndrome (ARDS) since the Berlin definition was published. The aim of this study is to identify clinically available predictors that distinguish between two phenotypes of fatal ARDS due to pneumonia. In total, 104 cases of Japanese patients with pneumonia-induced ARDS were extracted from our prospectively collected database. Fatal cases were divided into early (< 7 days after diagnosis) and late (≥ 7 days) death groups, and clinical variables and prognostic factors were statistically evaluated. Of the 50 patients who died within 180 days, 18 (36%) and 32 (64%) were in the early (median 2 days, IQR [1, 5]) and late (median 16 days, IQR [13, 29]) death groups, respectively. According to multivariate regression analyses, the APACHE II score (HR 1.25, 95%CI 1.12-1.39, p < 0.001) and the disseminated intravascular coagulation score (HR 1.54, 95%CI 1.15-2.04, p = 0.003) were independent prognostic factors for early death. In contrast, late death was associated with high-resolution computed tomography (HRCT) score indicating early fibroproliferation (HR 1.28, 95%CI 1.13-1.42, p < 0.001) as well as the disseminated intravascular coagulation score (HR 1.24, 95%CI 1.01-1.52, p = 0.039). The extent of fibroproliferation on HRCT, and the APACHE II scores along with coagulation abnormalities, should be considered for use in predictive enrichment and personalized medicine for patients with ARDS due to pneumonia.

Identifiants

pubmed: 34625618
doi: 10.1038/s41598-021-99540-1
pii: 10.1038/s41598-021-99540-1
pmc: PMC8501115
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20051

Informations de copyright

© 2021. The Author(s).

Références

J Thorac Dis. 2018 Oct;10(10):5796-5803
pubmed: 30505487
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Crit Care Med. 2010 Feb;38(2 Suppl):S35-42
pubmed: 20083912
Respir Med. 2011 Aug;105(8):1170-5
pubmed: 21570273
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Int J Antimicrob Agents. 2001;18 Suppl 1:S45-8
pubmed: 11574195
Lancet Respir Med. 2014 Aug;2(8):611-20
pubmed: 24853585
BMJ Open. 2017 Nov 8;7(11):e015330
pubmed: 29122783
Int J Antimicrob Agents. 2018 Jun;51(6):918-924
pubmed: 29501821
Chest. 2016 May;149(5):1155-64
pubmed: 26896701
Sci Rep. 2019 Jun 13;9(1):8601
pubmed: 31197186
Eur Respir J. 2018 Mar 29;51(3):
pubmed: 29545274
Radiology. 2006 Jan;238(1):321-9
pubmed: 16293804
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Chest. 2005 Aug;128(2):525-32
pubmed: 16100134
Crit Care Med. 2006 Mar;34(3):625-31
pubmed: 16521260
Intensive Care Med. 2015 Feb;41(2):222-30
pubmed: 25476984
Lancet. 1967 Aug 12;2(7511):319-23
pubmed: 4143721
Am Rev Respir Dis. 1985 Sep;132(3):485-9
pubmed: 4037521
Semin Respir Crit Care Med. 2019 Feb;40(1):19-30
pubmed: 31060085
Crit Care. 2017 Oct 20;21(1):254
pubmed: 29052522
Crit Care. 2017 Jun 8;21(1):135
pubmed: 28592332
Clin Infect Dis. 2004 Jul 15;39(2):165-9
pubmed: 15307023
Springerplus. 2016 Jul 28;5(1):1193
pubmed: 27516931
BMJ Open. 2012 Mar 01;2(2):e000545
pubmed: 22382117
Am J Respir Crit Care Med. 2002 Jun 1;165(11):1551-6
pubmed: 12045132
Intern Med. 2006;45(7):419-28
pubmed: 16679695
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24
pubmed: 7509706
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet Respir Med. 2013 Jul;1(5):395-401
pubmed: 24429204
Ann Am Thorac Soc. 2017 Jun;14(6):844-850
pubmed: 28570160
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Lancet Respir Med. 2019 Oct;7(10):870-880
pubmed: 31399381

Auteurs

Kazuya Ichikado (K)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan. kazuya-ichikado@saiseikaikumamoto.jp.

Kodai Kawamura (K)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Takeshi Johkoh (T)

Department of Radiology, Kansai Rosai Hospital, Amagasaki, Hyogo, 660-8511, Japan.

Kiminori Fujimoto (K)

Department of Radiology, Kurume University School of Medicine and Center for Diagnostic Imaging, Kurume University Hospital, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.

Ayumi Shintani (A)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Satoru Hashimoto (S)

Department of Anesthesiology and Intensive Care Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yoshitomo Eguchi (Y)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Yuko Yasuda (Y)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Keisuke Anan (K)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Naoki Shingu (N)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Yoshihiko Sakata (Y)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Junpei Hisanaga (J)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Tatsuya Nitawaki (T)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Miwa Iio (M)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Yuko Sekido (Y)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Kenta Nishiyama (K)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Kazunori Nakamura (K)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Moritaka Suga (M)

Division of Respiratory Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto, 861-4101, Japan.

Hidenori Ichiyasu (H)

Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Takuro Sakagami (T)

Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH